The Glucose Never Lies®

Episode 14: Overcoming Insulin Resistance in Type 1 Diabetes

John Pemberton Episode 14

In this deep-dive episode, John Pemberton explores the misunderstood world of insulin resistance in people with type 1 diabetes. Drawing on years of personal experience, clinical expertise, and the latest research, he breaks down why insulin resistance matters—even in a condition defined by insulin deficiency.

The episode walks through the 'Ominous Octet', eight mechanisms that drive insulin resistance, and explains how they impact blood glucose control, weight management, and long-term health. More importantly, it offers practical strategies to reduce total daily insulin dose through lifestyle changes, activity, nutrition, and pharmacological options.

Whether you're living with T1D, supporting someone who is, or simply want to better understand the complex interplay between insulin and the body, this episode provides clarity and direction.

Takeaways:

  • People with T1D often require more insulin due to lack of portal delivery and higher peripheral levels
  • Insulin resistance occurs in the liver, muscle, brain, kidneys, gut, and fat tissue
  • Measuring units per kilogram is a useful proxy for insulin sensitivity
  • Activity is the most powerful modifiable factor for improving insulin sensitivity
  • Weight loss, high-protein diets, and reduced saturated fat intake all help reduce resistance
  • GLP-1 and dual agonists (e.g., tirzepatide) show promise for T1D, but are not yet widely approved
  • SGLT2 inhibitors and pioglitazone offer targeted benefits but must be used with care
  • A multifaceted approach is often needed to lower insulin needs and support health

Chapters:
00:00 – Introduction & Purpose of the Episode
02:14 – Why Insulin Resistance Matters in T1D
04:35 – Portal vs Peripheral Insulin Delivery
06:50 – The Ominous Octet Explained
09:15 – How to Measure Your Insulin Sensitivity
11:30 – The 8 Causes of Insulin Resistance (Deep Dive)
22:35 – Lifestyle Solutions: Activity, Weight Loss, and Nutrition
31:40 – Pharmacological Options: GLP-1s, SGLT2s, and More
43:10 – Final Thoughts: Personal Reflection and Action Steps

Key Resources:

People on this episode